Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients

Panminerva Medica

Volumn 49, Issue 1, 2007, Pages 1-6

  Costa, C ^a   Libertucci, D ^b   Solidoro, P ^b   Sinesi, F ^a   Bergallo, M ^a   Margio, S ^a   Piana, F ^a   Baldi, S ^b   Cavallo, R ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Cytomegalovirus infections; Lung transplantation; Organ transplantation; Respiratory tract infections

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CYTOMEGALOVIRUS; FEMALE; HUMAN; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; LUNG LAVAGE; MALE; MIDDLE AGED; ORTHOMYXOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; VIROLOGY;

ADOLESCENT; ADULT; AGED; BRONCHOALVEOLAR LAVAGE; CYTOMEGALOVIRUS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES;

EID: 34547328526     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cells transplantation. Am J Respir Crit Care Med 2004;170:22-48.
2. Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 1998;12:116-22.
3. Legoff J, Guérot E, Ndjoyi-Mbiguino A, Matta M, Si-Mohamed A, Gutmann L et al. High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assays. J Clin Microbiol 2005;43:455-7.
4. de Maar EF, Verschuuren EAM, Harmsen MC, The TH, van Son WJ. Pulmonary involvement during cytomegalovirus infection in immunocompromised patients. Transpl Infect Dis 2003;5:112-20.
5. Hohenthal U, Itälä M, Salonen J, Sipilä J, Rantakokko-Jalava K, Meurman O et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy - value of new microbiological methods. Eur J Haematol 2005;74:203-11.
6. File TM. Community-acquired pneumonia. Lancet 2003;362:1991-2001.
7. Garbino J, Sommer R, Gerber A, Regamey C, Vernazza P, Genne D et al. Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. Int J Infect Dis 2002;6:288-93.
8. File TM. The epidemiology of respiratory tract infections. Semin Respir Infect 2000; 15:184-94.
9. Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy. Curr Opin Infect Dis 2001;14:703-9.
10. Kim EA, Lee KS, Primack SL, Yoon HK, Byun HS, Kim TS et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002;22:S137-49.
11. Garbino J, Gerbase MW, Wunderli W, Deffemez C, Thomas Y, Rochat T et al. Lower respiratory viral illnesses. Improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 2004;170:1197-203.
12. van Elden LTR, van Kraaij MGJ, Nijhuis M, Hendriksen KAW, Dekker AW, Rozenberg-Arska M et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with haematological cancer and pneumonia. Clin Infect Dis 2002;34:177-83.
13. Eriksson BM, Brytting M, Zweygberg-Wirgart B, Hillerdal G, Olding-Stenkvist E, Linde A. Diagnosis of cytomegalovirus in bronchoalveolar lavage by polymerase chain reaction, in comparison with virus isolation and detection of viral antigen. Scand J Infect Dis 1993;25: 421-7.
14. Klech H, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989;2:561-85.
15. Zavattoni M, Percivalle E, Cattaneo E, Revello MG, Torsellini M, Gerna G. Optimized detection of respiratory viruses in nasopharyngeal secretions. New Microbiol 2003;26:133-40.
16. Rovida F, Percivalle E, Zavattoni M, Torsellini M, Sarasini A, Campanini G et al. Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J Med Virol 2005;75:336-47.
17. Tamm M, Traenkle P, Grilli B, Solèr M, Bolliger CT, Dalquen P et al. Pulmonary cytomegalovirus infection in immunocompromised patients. Chest 2001;119:838-43.
18. Balthesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993;67: 5360-6.
19. Enright H, Haake R, Weisdorf D, Ramsay N, McGlave P, Kersey J et al. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 1993 ;55:1339-46.
20. rd. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114:195-202.
21. Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors. Transplantation 1996;61:560-6.
22. van Son WJ, Peset R, Duipmans JC, van der Mark TW, The TH, Tegzess AM. Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. Transplantation 1987;44:149-50.
23. de Maar EF, Kas-Deelen AM, van der Mark TW, The TH, Tegzess AM, Ploeg RJ et al. Cytomegalovirus pneumonitis after kidney transplantation is not caused by plugging of cytomegalic endothelial cells only. Transplant Int 1999;12:56-62.
24. Sanchez JL, Kruger RM, Paranjothi S, Trulock EP, Lynch JP, Hicks C, et al. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001;72: 733-5.
25. Humar A, Gregson D, Caliendo AM, McGeer A, Malkan G, Krajden M et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68:1305-11.
26. Senechal M, Dorent R, du Monteei ST, Fillet AM, Ghossoub JJ, Dubois M et al. Monitoring of human cytomegalovirus infections in hearth transplant recipients by pp65 antigenemia. Clin Transplant 2003;17:423-7.
27. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355:2032-6.